Patents by Inventor Roland Paul Howe

Roland Paul Howe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5976369
    Abstract: Biological assay systems often involve suspending magnetically attractable particles in a liquid, and later bringing down the particles from suspension and separating the formed pellet from the supernatant liquid. The invention provides magnetic systems for this purpose, shaped to form an annular or part-annular pellet close to the bottom of the vessel. The systems are suitable for automation.
    Type: Grant
    Filed: April 2, 1998
    Date of Patent: November 2, 1999
    Assignee: Amersham International plc
    Inventors: Roland Paul Howe, Michael Alan Reeve, Daniel Bischof
  • Patent number: 5897783
    Abstract: Biological assay systems often involve suspending magnetically attractable particles in a liquid, and later bringing down the particles from suspension and separating the formed pellet from the supernatant liquid. The invention provides magnetic systems for this purpose, shaped to form an annular or part-annular pellet close to the bottom of the vessel. The systems are suitable for automation.
    Type: Grant
    Filed: October 13, 1995
    Date of Patent: April 27, 1999
    Assignee: Amersham International plc
    Inventors: Roland Paul Howe, Michael Alan Reeve, Daniel Bischof
  • Patent number: 5849542
    Abstract: A method of sequencing a target nucleic acid using primer extension mass spectroscopy to generate an observed mass spectrum, on which base calling cycles are carried out using calibrated inter-peak mass difference values such that: each called base allows mass calculation for the base-called peak in the observed mass spectrum; this calculated mass is then used as a further calibration point for subsequent rounds of base calling. A reaction mixture of all four base-specific chain extension nucleotides and four chain termination nucleotide analogues. A method of performing mass spectroscopy, which method comprises subjecting molecular ions which have been chemically charged in a predetermined manner to time-of-flight or Fourier transform mass spectroscopy.
    Type: Grant
    Filed: May 10, 1996
    Date of Patent: December 15, 1998
    Assignee: Amersham Pharmacia Biotech UK Limited
    Inventors: Michael Alan Reeve, Roland Paul Howe, Terek Schwarz